Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials

WHAT IS KNOWN AND OBJECTIVE: Edaravone is a new antioxidant and hydroxyl radical scavenger. Although there is evidence that it improves clinical outcomes of patients with acute ischaemic stroke (AIS), it is not yet widely accepted for treatment of AIS in Western countries. We further investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chongyue, Li, Mingkai, Lin, Liling, Chen, Shuying, Chen, Yongru, Hong, Liekai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359409/
https://www.ncbi.nlm.nih.gov/pubmed/33638896
http://dx.doi.org/10.1111/jcpt.13392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359409/
https://www.ncbi.nlm.nih.gov/pubmed/33638896
http://dx.doi.org/10.1111/jcpt.13392

Ejemplares similares